<DOC>
	<DOCNO>NCT02169349</DOCNO>
	<brief_summary>The purpose study develop ultra sensitive assay mutation detection circulate tumor DNA ( ctDNA ) treatment , diagnosis monitoring disease progression Non-Small Cell Lung Cancer ( NSCLC ) .</brief_summary>
	<brief_title>Molecular Diagnosis Circulating Tumor DNA Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Signed write informed consent Male female age &gt; = 18 year Stage IIIb IV Non Small Cell Lung Cancer histologically confirm Tissue plasma sample provide mutation analysis Unwilling unable provide inform consent Any serious medical condition would interfere subject 's safety</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>